Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics Revenue

Nurix Therapeutics had revenue of $7.89M in the quarter ending August 31, 2025, a decrease of -37.29%. This brings the company's revenue in the last twelve months to $83.69M, up 48.32% year-over-year. In the fiscal year ending November 30, 2024, Nurix Therapeutics had annual revenue of $54.55M, down -29.15%.

• Revenue (ttm): $83.69M
• Revenue Growth: +48.32%
• P/S Ratio: 18.93
• Revenue / Employee: $292,612
• Employees: 286
• Market Cap: 1.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Nov 30, 2024	54.55M	-22.44M	-29.15%
Nov 30, 2023	76.99M	38.36M	99.31%
Nov 30, 2022	38.63M	8.88M	29.84%
Nov 30, 2021	29.75M	11.93M	66.95%
Nov 30, 2020	17.82M	-13.30M	-42.73%
Nov 30, 2019	31.12M	-6.33M	-16.91%
Nov 30, 2018	37.45M	-	-